French health startup Alan hits €5B valuation after €100M raise
What's the deal? French health insurance startup Alan has raised €100 million ($116 million) in a new funding round led by existing backer Index Ventures, pushing its valuation above €5 billion. New investors include Greenoaks, Kaaf InvestmentsDealroom has a profile for this one. Try Dealroom →, and SH CapitalDealroom has a profile for this one. Try Dealroom →, alongside Belgian bank BelfiusDealroom has a profile for this one. Try Dealroom → and — in an unusual twist — Shopify founder Tobi LütkeDealroom has a profile for this one. Try Dealroom → and French footballer Antoine GriezmannDealroom has a profile for this one. Try Dealroom →.
The Paris-based company, founded in 2016, has grown into a digital health platform that bundles insurance with access to doctors and wellness tools. It now serves more than one million customers across France, Belgium, Spain, and Canada.
Why now? Alan has hit a meaningful milestone: it has reached operational break-even in France, its home market. Annual recurring revenue hit €785 million in 2025, up 53% year on year, and the company is targeting €1 billion by the end of this year. That combination of scale and a credible path to profitability makes for a compelling fundraising story.
It also recently won a contract to provide health coverage for up to 135,000 French civil servants — a significant vote of confidence from the state.
What could go wrong? Alan is still loss-making overall, with net losses of €56 million in 2024. The company has said it is willing to delay full profitability in order to fund international expansion — a trade-off that investors are accepting for now, but one that could become harder to justify if growth slows.
Healthcare regulation varies significantly across markets, and scaling in Canada and Spain while maintaining momentum in France is a complex juggling act.
The signal: Alan is part of a broader wave of European startups building "super-apps" that bundle financial and health services together, betting that integrated platforms command higher loyalty — and higher valuations — than single-product companies.
At €5 billion, it is one of Europe's most valuable insurtech companies, and its progress toward profitability offers a counterpoint to the narrative that European tech cannot produce capital-efficient growth businesses. The presence of sovereign-wealth-linked backers like Kaaf Investments also signals growing Gulf interest in European health tech.
Sources:
Maddyness
Life Insurance International
Bloomberg
Tech Funding News
The Globe and Mail
Silicon Republic
The Tech Buzz
Startup Researcher
Image credit:
Alan
J.V.
